ARCHIVES

Rosenberg’s Latest Results: 22% Response Seen With LAK/IL-2, 13% With High Dose IL-2 Alone

This article is from The Cancer Letter archive.

Vol. 13 No. 15 | April 10, 1987

Download PDF Visit The Full Archive

Related Articles

FDA Approves Merck’s Gardasil Vaccine To Prevent Cervical Cancer.

June 9, 2006

Funding Opporunities: Program Announcments

January 15, 1999

Cervical Screening Should Emphasize Older Women, ASP Members Told

March 14, 1986

ACS-Roosevelt Awards Go to 19 New Fellows

July 30, 1976

ODAC Reviews Post-Marketing Studies for Eight Indications

February 21, 2003

The First BRCA1 Test Hits The Market; Are Oncologists, Patients Ready?

January 26, 1996